1620 Investment Advisors, Inc. Tandem Diabetes Care Inc Transaction History
1620 Investment Advisors, Inc.
- $125 Million
- Q1 2025
A detailed history of 1620 Investment Advisors, Inc. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 25 shares of TNDM stock, worth $495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$495% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNDM
# of Institutions
295Shares Held
72.1MCall Options Held
3.12MPut Options Held
159K-
Black Rock Inc. New York, NY11.1MShares$220 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.29MShares$145 Million0.0% of portfolio
-
Sessa Capital Im, L.P. New York, NY4.47MShares$88.5 Million3.55% of portfolio
-
Gw&K Investment Management, LLC Boston, MA2.86MShares$56.8 Million0.51% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.72MShares$53.8 Million0.95% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $1.27B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...